Adiponectin isoform distribution in women-relationship to female sex steroids and insulin sensitivity

Metabolism: Clinical and Experimental

Volumn 58, Issue 2, 2009, Pages 239-245

  Leung, Kin Chuen ^a   Xu, Aimin ^b   Craig, Maria E ^a,c   Martin, Allison ^d   Lam, Karen S L ^b   O'Sullivan, Anthony J ^e  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e ST GEORGE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ESTRADIOL; GLUCOSE; INSULIN; PROGESTERONE; SEX HORMONE;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; ESTROGEN BLOOD LEVEL; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LINEAR REGRESSION ANALYSIS; MULTIVARIATE ANALYSIS; NORMAL HUMAN; POSTMENOPAUSE; PREGNANCY; PREMENOPAUSE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL;

ADIPONECTIN; ADIPOSE TISSUE; ADULT; AGED; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; ESTRADIOL; FEMALE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; ISOMERISM; LINEAR MODELS; MOLECULAR WEIGHT; MULTIVARIATE ANALYSIS; PREGNANCY; PROGESTERONE;

EID: 58249130623     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.09.020     Document Type: Article

References (41)

1. O'Sullivan A.J., Martin A., and Brown M.A. Efficient fat storage in postmenopausal women and in early pregnancy: a role for estrogen. J Clin Endocrinol Metab 86 (2001) 4951-4956
2. Carr M.C. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 88 (2003) 2404-2411
3. Kaaja R.J., and Greer I.A. Manifestations of chronic disease during pregnancy. JAMA 294 (2005) 2751-2757
4. Salpeter S.R., Walsh J.M.E., Ormiston T.M., Greyber E., Buckley N.S., and Salpeter E.E. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diab Obes Metab 8 (2006) 538-554
5. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 273 (1995) 199-208
6. Kirwan J.P., Hauguel-De Mouzon S., Lepercq J., et al. TNF-α is a predictor of insulin resistance in human pregnancy. Diabetes 51 (2002) 2207-2213
7. Butte N.F. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr 71 Suppl (2000) 1256S-1261S
8. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21 (2000) 697-738
9. O'Sullivan A.J., Kriketos A.D., Martin A., and Brown M.A. Serum adiponectin levels in normal and hypertensive pregnancy. Hypertension Preg 25 (2006) 193-203
10. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett 580 (2006) 2917-2921
11. Whitehead J.P., Richards A.A., Hickman I.J., Macdonald G.A., and Prins J.B. Adiponectin-a key adipokine in the metabolic syndrome. Diab Obes Metab 8 (2006) 264-280
12. Oh D.K., Giaraldi T., and Henry R.R. Adiponectin in health and disease. Diab Obes Metab 9 (2007) 282-289
13. Tsao T.S., Murrey H.E., Hug C., Lee D.H., and Lodish H.F. Oligomerization state-dependent activation of NF-κB signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J Biol Chem 277 (2002) 29359-29362
14. Tsao T.-S., Tomas E., Murrey H.E., et al. Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J Biol Chem 278 (2003) 50810-50817
15. Waki H., Yamauchi T., Kamon J., et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 278 (2003) 40352-40363
16. Yamauchi T., Kamon J., Minokoshi Y., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Med 8 (2002) 1288-1295
17. Yoon M.J., Lee G.Y., Chung J.-J., Ahn Y.H., Hong S.H., and Kim J.B. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes 55 (2006) 2562-2570
18. Pajvani U.B., Hawkins M., Combs T.P., et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 279 (2004) 12152-12162
19. Degawa-Yamauchi M., Moss K.A., Bovenkerk J.E., et al. Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor α. Obes Res 13 (2005) 662-669
20. Xu A., Wang Y., Keshaw H., Xu L.Y., Lam K.S.L., and Cooper G.J.S. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 112 (2003) 91-100
21. Xu A., Chan K.W., Hoo R.L.C., et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem 280 (2005) 18073-18080
22. Gavrila A., Chan J.L., Yiannakouris N., et al. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab 88 (2003) 4823-4831
23. Jürimäe J., and Jürimäe T. Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral and metabolic variables. Am J Physiol Endocrinol Metab 293 (2007) E42-E47
24. Sieminska L., Wojciechowska C., Niedziolka D., et al. Effect of postmenopause and hormone replacement therapy on serum adiponectin levels. Metab Clin Exp 54 (2005) 1610-1614
25. Naruse K., Yamasaki M., Umekage H., Sado T., Sakamoto Y., and Morikawa H. Peripheral blood concentrations of adiponectin, an adipocyte-specific plasma protein, in normal pregnancy and preeclampsia. J Reprod Immunol 65 (2005) 65-75
26. Catalano P.M., Hoegh M., Minium J., et al. Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia 49 (2006) 1677-1685
27. Fuglsang J., Skjærbæk C., Frystyk J., Flyvbjerg A., and Ovesen P. A longitudinal study of serum adiponectin during normal pregnancy. BJOG 113 (2006) 110-113
28. Nien J.K., Nazaki-Tovi S., Romero R., et al. Plasma adiponectin concentrations in non-pregnant, normal and overweight pregnant women. J Perinatal Med 35 (2007) 522-531
29. Kleiblová P., Springer D., and Haluzík M. The influence of hormonal changes during menstrual cycle on serum adiponectin concentrations in healthy women. Physiol Res 55 (2006) 661-666
30. Lara-Castro C., Luo N., Wallace P., Klein R.L., and Garvey W.T. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 25 (2006) 249-259
31. Kern P.A., Di Gregorio G.B., Lu T., Rassouli N., and Ranganathan G. Adiponectin expression from human adipose tissue. Relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 52 (2003) 1779-1785
32. Motoshima H., Wu X., Sinha M.K., et al. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab 87 (2002) 5662-5667
33. Combs T.P., Berg A.H., Rajala M.W., et al. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 52 (2003) 268-276
34. Scherer P.E., Williams S., Fogliano M., Baldini G., and Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270 (1995) 26746-26749
35. Ferrara C.M., Lynch N.A., Nicklas B.J., Ryan A.S., and Berman D.M. Differences in adipose tissue metabolism between postmenopausal and perimenopausal women. J Clin Endocrinol Metab 87 (2002) 4166-4170
36. Palin S.L., McTernan P.G., Anderson L.A., Sturdee D.W., Barnett A.H., and Kumar S. 17b-Estradiol and anti-estrogen ICI: compound 182,780 regulate expression of lipoprotein lipase and hormone-sensitive lipase in isolate subcutaneous abdominal adipocytes. Metab Clin Exp 52 (2003) 383-388
37. Tschritter O., Fritsche A., Thamer C., et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52 (2003) 239-243
38. Fisher F.F.M., Trujillo M.E., Hanif W., et al. Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males. Diabetologia 48 (2005) 1084-1087
39. Bobbert T., Rochlitz H., Wegewitz U., et al. Changes of adiponectin oligomer composition by moderate weight reduction. Diabetes 54 (2005) 2712-2719
40. Aso Y., Yamamoto R., Wakabayashi S., et al. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes 55 (2006) 1954-1960
41. Blüher M., Brennan A.M., Kelesidis T., et al. Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays. Diabetes Care 30 (2007) 280-285